THE DUBERSTEIN GROUP INC. for PHRMA INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reimported drugs from Canada - HR 2112, Consolidated and Further Continuing Appropriations Act, 2012.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN | — |
| STEVEN CHAMPLIN | — |
| KENNETH DUBERSTEIN | — |
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
| MARTI THOMAS | — |
| ERIC UELAND | — |
Trade (domestic/foreign) TRD
Monitor Korea, Colombia and Panama Free Trade Agreements - HR 3078, United States-Colombia Trade Promotion Agreement Implementation Act; HR 3079, United States-Panama Trade Promotion Agreement Implementation Act; HR 3080, United States-Korea Free Trade Agreement Implementation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN | — |
| STEVEN CHAMPLIN | — |
| KENNETH DUBERSTEIN | — |
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
| MARTI THOMAS | — |
| ERIC UELAND | — |
Medicare/Medicaid MMM
Impact of deficit reduction issues and actions of the Joint Committee on Deficit Reduction on Medicare and Medicare Part D - proposed legislation re these issues. Sustainable growth rate and impact on other Medicare programs - HR 3630, Temporary Payroll Tax Cut Continuation Act of 2011; HR 3765, Temporary Payroll Tax Cut Continuation Act of 2011.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BERMAN | — |
| STEVEN CHAMPLIN | — |
| KENNETH DUBERSTEIN | — |
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
| MARTI THOMAS | — |
| ERIC UELAND | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.